2024年11月8日,万基遗传公司(MYGN.OQ)在盘中股价大涨6%,引发了市场的广泛关注。这与该公司于前一日晚些时候公布的2024年第三季度财报表现出色密切相关。
具体而言,万基遗传公司公布的该季度每股收益为6美分,高于分析师预期的2美分,同时也高于去年同期的亏损3美分。当季营收达到2.133亿美元,同比增长11.2%,也超出了分析师的预期。
尽管当季度净亏损2210万美元,但由于优于预期的整体业绩表现,再加上分析师对公司未来利润的预期被上调,投资者对公司的长期增长前景持乐观看法,推动了公司股价的大涨。不少分析师认为,万基遗传的业绩将持续复苏,为后续持续上涨奠定基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.